Biologik ApSActive
Key figures
Key ratios
2024/25Balance sheet structure
Dividends
proposedProposed dividend for the financial year 63.300 kr. (27% of the profit for the year).
Proposed dividend for the financial year from the annual report's profit allocation (normally paid the following year after the annual general meeting).
Financial statements2018–2025
| 2017/18 | 2018/19 | 2019/20 | 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||||
| Cash and cash equivalents | 423.707 | 584.048 | 335.495 | 620.308 | 253.229 | 421.823 | 298.271 | 421.600 |
| Total current assets | 423.707 | 585.746 | 399.120 | 627.080 | 437.363 | 463.092 | 340.743 | 552.971 |
| Total non-current assets | — | — | — | — | — | — | — | — |
| Total assets | 423.707 | 585.746 | 399.120 | 627.080 | 437.363 | 463.092 | 340.743 | 552.971 |
| Balance sheet — liabilities and equity | ||||||||
| Current liabilities | 316.991 | 348.591 | 200.285 | 213.353 | 169.497 | 133.765 | 105.664 | 144.393 |
| Non-current liabilities | — | — | — | — | — | — | — | — |
| Total liabilities | 316.991 | 348.591 | 200.285 | 213.353 | 169.497 | 133.765 | 105.664 | 144.393 |
| Share capital | 50.000 | 50.000 | 50.000 | 50.000 | 50.000 | 50.000 | 50.000 | 50.000 |
| Retained earnings of previous periods | 3.816 | 87.155 | 148.835 | 307.227 | 160.666 | 220.427 | 124.079 | 295.278 |
| Profit for the year | 173.671 | 183.339 | 61.680 | 214.892 | -89.361 | 118.661 | -35.348 | 234.499 |
| Total equity | 106.716 | 237.155 | 198.835 | 413.727 | 267.866 | 329.327 | 235.079 | 408.578 |
| Income statement | ||||||||
| Gross profit | 714.455 | 831.546 | 377.588 | 592.846 | 258.073 | 653.018 | 400.167 | 385.601 |
| Operating profit | 224.510 | 238.359 | 83.995 | 284.887 | -107.623 | 157.672 | -41.970 | 302.671 |
| Profit before income tax | 224.510 | 237.278 | 82.140 | 280.760 | -111.605 | 156.897 | -41.970 | 304.619 |
| Profit for the reporting year | 173.671 | 183.339 | 61.680 | 214.892 | -89.361 | 118.661 | -35.348 | 234.499 |
| Labour costs | 489.945 | 593.187 | 293.593 | 307.959 | 365.696 | 495.346 | 442.137 | 82.930 |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — |
| Other indicators | ||||||||
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Dividends | 52.900 | 100.000 | 0 | 56.500 | 57.200 | 58.900 | 61.000 | 63.300 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
About the company
Annual report 2025Selskabets væsentligste aktiviteter består i salg af bøger, kurser og foredrag til private, samt efteruddannelse af sundhedsprofesionelle og konsulentydelser indenfor sunhed og bioteknologi.
Selskabets resultatopgørelse for regnskabsåret 1. juli 2024 - 30. juni 2025 udviser et resultat på kr. 234.499, og selskabets balance pr. 30. juni 2025 udviser en balancesum på kr. 552.971, og en egenkapital på kr. 408.578.
Excerpt from the management's review in the latest annual report.